Okami Medical Secures $45M Funding Led by Gilde Healthcare

Why It Matters

The funding provides Okami Medical with the resources to scale its innovative vascular therapies, positioning it to capture market share in a high‑growth segment of medical devices and potentially improve outcomes for patients with vascular disease.

Deal Summary

Okami Medical, a medical‑technology firm specializing in vascular embolization, announced the close of an oversubscribed $45 million financing. The round was led by new investor Gilde Healthcare with participation from existing backers Vensana Capital and U.S. Venture Partners.